Wellnex Life sees innovation and cannabis as organic growth drivers in health and wellness

Wellnex Life Ltd (ASX:WNX) CEO George Karafotias speaks to Proactive about Wellnex's strategy for growth in the Australian health and wellness market. Wellnex recently signed a supply agreement with industry giant GSK for "Australia's first liquid paracetamol product in a soft gel" and Karafotias believes a strategy of creating innovative consumer healthcare products is now drawing the attention of retailers and consumers. Karafotias adds that Wellnex Life will continue to focus on creating innovative new products, including medicinal cannabis, as these are more attractive to retailers. #proactiveinvestors #wellnexlife #wellness